Abstract
A novel series of 2,4,6-trisubstituted 1,3,5-triazine derivatives bearing aryl hydrazone moiety were designed and synthesized under the guidance of scaffold hopping and bioisosterism from the autophagy inhibitor VLX600. The target compounds were evaluated for cytotoxicity against HT-29 by MTT assay with VLX600 as positive control. Then, ten potent target compounds (5c-5f, 5i-5r, 5s, 5t) were further evaluated against two cancer cell lines H460 and A549 and one normal cell line WI-38. Most of them exhibited significant cytotoxicity against one or more cell lines. Particularly, a promising compound 5f was identified, which exhibited the most potent cytotoxicity against HT-29, H460 and A549 cancer cell lines with IC50 values of 0.047 M, 0.071 M and 0.071 M, respectively, which was 10- to 62-folds more potent than VLX600 (IC50 = 0.47 M, 4.1 M, 4.4 M). The preliminary structure-activity relationships (SARs) of the compounds were also discussed.
Keywords: 2, 4, 6-trisubstituted 1, 3, 5-triazine, VLX600, cytotoxicity, synthesis, SAR.
Medicinal Chemistry
Title:Design, Synthesis, and Cytotoxicity of Novel 2,4,6-Trisubstituted 1,3,5- triazines Bearing Aryl Hydrazone Moiety as Potent Antitumor Agent
Volume: 12 Issue: 7
Author(s): Limei Wang, Sijia Zhao, Guanglong Bao, Yu Zhang, Shuancheng Xi, Guolin Zhou, Xin Zhai and Ping Gong
Affiliation:
Keywords: 2, 4, 6-trisubstituted 1, 3, 5-triazine, VLX600, cytotoxicity, synthesis, SAR.
Abstract: A novel series of 2,4,6-trisubstituted 1,3,5-triazine derivatives bearing aryl hydrazone moiety were designed and synthesized under the guidance of scaffold hopping and bioisosterism from the autophagy inhibitor VLX600. The target compounds were evaluated for cytotoxicity against HT-29 by MTT assay with VLX600 as positive control. Then, ten potent target compounds (5c-5f, 5i-5r, 5s, 5t) were further evaluated against two cancer cell lines H460 and A549 and one normal cell line WI-38. Most of them exhibited significant cytotoxicity against one or more cell lines. Particularly, a promising compound 5f was identified, which exhibited the most potent cytotoxicity against HT-29, H460 and A549 cancer cell lines with IC50 values of 0.047 M, 0.071 M and 0.071 M, respectively, which was 10- to 62-folds more potent than VLX600 (IC50 = 0.47 M, 4.1 M, 4.4 M). The preliminary structure-activity relationships (SARs) of the compounds were also discussed.
Export Options
About this article
Cite this article as:
Wang Limei, Zhao Sijia, Bao Guanglong, Zhang Yu, Xi Shuancheng, Zhou Guolin, Zhai Xin and Gong Ping, Design, Synthesis, and Cytotoxicity of Novel 2,4,6-Trisubstituted 1,3,5- triazines Bearing Aryl Hydrazone Moiety as Potent Antitumor Agent, Medicinal Chemistry 2016; 12 (7) . https://dx.doi.org/10.2174/1573406412666160106154551
DOI https://dx.doi.org/10.2174/1573406412666160106154551 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Proteomics in Computer-Aided Drug Design
Current Computer-Aided Drug Design The Application of X-ray, NMR, and Molecular Modeling in the Design of MMP Inhibitors
Current Topics in Medicinal Chemistry Targeting the Akt Kinase to Modulate Survival, Invasiveness and Drug Resistance of Cancer Cells
Current Medicinal Chemistry Isatoic Anhydride: A Fascinating and Basic Molecule for the Synthesis of Substituted Quinazolinones and Benzo di/triazepines
Current Organic Chemistry 1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer’s Disease Mice
Current Alzheimer Research Relationship Between Age-Related Postural Hyperkyphosis and Sarcopenia
Current Aging Science Design and Development of Anti-Hepatitis B Virus Agents
Current Medicinal Chemistry Interest of α2-Adrenergic Agonists and Antagonists in Clinical Practice: Background, Facts and Perspectives
Current Topics in Medicinal Chemistry Antibacterial and Phagocytic Properties of a Novel Silver-Interferon Complex
Anti-Infective Agents Anti-Viral
Current Bioactive Compounds Water-Soluble CdS Nanospheres Assembled from Quantum Dots
Current Nanoscience Demographic, Clinical, and Investigational Characteristics of COVID-19- related Guillain-Barré Syndrome with Differences from Typical and Another Virus-related Guillain-Barré Syndrome
Infectious Disorders - Drug Targets Fragment-Based Drug Design: Computational and Experimental State of the Art
Combinatorial Chemistry & High Throughput Screening Kikuchi-fujimoto Disease in the Axilla after COVID-19 Vaccination: A Case Report
Current Medical Imaging Synthesis, β -catenin Translocation Capability and ALP Activation Activity of 7H-thiazolo[3,2-b]-1,2,4-triazin-7-one Derivatives
Medicinal Chemistry Targeting Platelet G-Protein Coupled Receptors (GPCRs): Looking Beyond Conventional GPCR Antagonism
Current Vascular Pharmacology Microfluidic Paper-based Device for Medicinal Diagnosis
Current Topics in Medicinal Chemistry Central Countries' and Brazil's Contributions to Nanotechnology
Current Nanomaterials Biological Relevance of Lysophospholipids and Green Solutions for Their Synthesis
Current Organic Chemistry Design, Synthesis and Biological Evaluation of Novel Heterocyclic Fluoroquinolone Citrate Conjugates as Potential Inhibitors of Topoisomerase IV: A Computational Molecular Modeling Study
Current Drug Discovery Technologies